DAY 1 (November 17th)

• 08:20-08:30 Welcome Address: Luis Castillo

ACUTE LEUKEMIAS
• 08:30-09:15 Prognostic factors: Anthony Moorman

LEUKEMIA BOARD I
• 09:15-10:30 Clinical Case of Acute Lymphoblastic Leukemia: Multidisciplinary Discussion

COFFEE BREAK

CLASSIFICATION OF ALL
• 11:00-11:40 Is Cytogenetics relevant in the Genomic era?: Oskar Haas

MRD IN ACUTE LYMPHOBLASTIC LEUKEMIAS
• 11:40-12:10 Relevance and New Techniques Applied for the Detection of MRD: Eva Fronkova

MIXED PHENOTYPE ACUTE LEUKEMIAS (MPAL)
• 12:10-12:40 Characterization and prognosis: Speaker to be confirmed

GENOMIC PROFILING OF HEMATOLOGIC MALIGNANCIES BY FOUNDATION MEDICINE
• 12:40-13:10 FoundationOne® Heme: Speaker to be confirmed from Roche

QUESTIONS AND DISCUSSION

DAY 2 (November 18th)

COOPERATIVE PROJECTS BETWEEN EUROPE AND LATIN AMERICA
• 08:30-08:50 CLOSER: Mireia Camos
• 08:50-09:20 HARMONY: Anthony Moorman

LEUKEMIA BOARD II
• 09:20-10:35 Clinical Case of Acute Myeloid Leukemia: Multidisciplinary Discussion

COFFEE BREAK
• 10:35-11:05

ALL-IC-2009
• 11:05-11:35 Results: Myriam Campbell

NEW THERAPEUTIC STRATEGIES IN ACUTE LEUKEMIAS
• 11:35- 12:15 CAR T-cell in ALL: When and What to Expect? Indication & Complications: Susana Rives
• 12:15-12:45 ALL-IC 2022: Marisa Felice
• 12:45-13:15 New Strategies in AML: Speaker to be confirmed

ADOLESCENTS
• 13:15-13:35 Transition from children’s hospital to adult hospital: María Imbert

QUESTIONS AND DISCUSSION
• 13:35-13:55
• 13:55-14:00 Closing: Luis Castillo